‘Concerning’ CT scans may cause unnecessary hospitalization for some pulmonary embolism patients

Some pulmonary embolism patients may be hospitalized unnecessarily due to CT imaging results rather than clinical risk factors, a study finds. Roughly half of the low risk patients had CT imaging features that physicians consider “concerning”, and these patients fared just as well in the hospital as those whose CT scans showed no concerning findings.

Hackensack Meridian Mountainside Medical Center Receives the HeartFlow® CT Quality Award for Commitment to Patients’ Heart Health

Mountainside received the HeartFlow® CT Quality Award. Honorees are in the top 22% of medical centers providing patients with better pathways for identifying and understanding heart health using CT scans and HeartFlow® Analysis, a groundbreaking technology for diagnosing coronary artery disease.

Global contrast media shortage: Strategies for conservation

In wake of the global shortage of iodinated contrast media, researchers modeled several ways to conserve it. They found that a combination of methods could reduce contrast media use for CT scans by approximately 80% if a moderate reduction in diagnostic accuracy could be tolerated. They say changes must be made to minimize supply chain risk in the future.

First Report of Minimally Invasive Aortic Valve Replacement Using Real-Time CT Imaging in Elderly Man with Heart Failure and Blood Clot

Cardiologists from the Structural and Congenital Heart Center and Cardiac Surgeons at Hackensack Meridian Hackensack University Medical Center/Hackensack Meridian School of Medicine have reported what is believed to be the very first patient with heart failure and a blood clot to undergo a minimally invasive transcatheter aortic valve replacement using CT (computed tomography) fusion imaging, a technique that employs two different imaging modalities.

New Tool for an Old Disease: Use of PET and CT Scans May Help Develop Shorter TB Treatment

Experts believe that tuberculosis, or TB, has been a scourge for humans for some 15,000 years, with the first medical documentation of the disease coming out of India around 1000 B.C.E. Today, the World Health Organization reports that TB is still the leading cause of death worldwide from a single infectious agent, responsible for some 1.5 million fatalities annually. Primary treatment for TB for the past 50 years has remained unchanged and still requires patients to take multiple drugs daily for at least six months. Successful treatment with these anti-TB drugs — taken orally or injected into the bloodstream — depends on the medications “finding their way” into pockets of TB bacteria buried deep within the lungs.